A utophagy is a catabolic mechanism that is evolutionarily conserved from yeast to mammals. According to how the degrading components are delivered to the lysosomes, the autophagy can be further classified into macroautophagy, microautophagy, and chaperone-mediated autophagy. Macroautophagy is the most common form of autophagy. During macroautophagy (abbreviated as autophagy), unnecessary or dysfunctional cellular components from stressed cells are degraded to provide energy. Under normal physiological conditions, this process is suppressed to a basal level by the serine/threonine protein kinase mammalian target of rapamycin (mTOR). Upon starvation or rapamycin treatment, the inhibitory effects of mTOR on its target, autophagy-related gene (atg) proteins, are relieved. Atg proteins form complexes on the phagophore assembly sites and initiate autophagosome formation.
A utophagy is a catabolic mechanism that is evolutionarily conserved from yeast to mammals. According to how the degrading components are delivered to the lysosomes, the autophagy can be further classified into macroautophagy, microautophagy, and chaperone-mediated autophagy. Macroautophagy is the most common form of autophagy. During macroautophagy (abbreviated as autophagy), unnecessary or dysfunctional cellular components from stressed cells are degraded to provide energy. Under normal physiological conditions, this process is suppressed to a basal level by the serine/threonine protein kinase mammalian target of rapamycin (mTOR). Upon starvation or rapamycin treatment, the inhibitory effects of mTOR on its target, autophagy-related gene (atg) proteins, are relieved. Atg proteins form complexes on the phagophore assembly sites and initiate autophagosome formation. 1 Other autophagyinducing pathways independent of mTOR are also known. 2 For example, an increased release of lumenal Ca 2þ to the cytosol induces a downstream signaling cascade leading to mTORindependent autophagy. 3 However, many mTOR-independent autophagy induction pathways have yet to be elucidated. Considering the complexity of cellular signaling networks, vast uncertainties regarding autophagy induction and control remain. Autophagy plays an essential role in maintaining the homeostasis of cells. The inability to regulate autophagy is associated with aging, 4 neurodegeneration, 5 cancer, 6 type-2 diabetes, 7 and atherosclerosis. 8 For example, autophagy blockade that disables a cell's ability to degrade overexpressed R-synuclein may be a cause of Parkinson's disease. 9 Autophagy deficiency also increases the risk of tumorigenesis. 6 Once the tumor is established, tumor cells rely on autophagy to protect them against metabolic stress and drug therapy. 6, 10 But if the autophagy was kept at a relatively high level, cells may undergo autophagic cell death. 11 Thus, some therapeutic agents that could induce autophagic cell death in tumor cells are promising as a useful supplement to current cancer treatment strategies. 12 Therefore, the role of autophagy in physiology and pathology is very complex, and its precise regulation is essential. A bottleneck in the development of therapeutics is a shortage of pharmacological tools that modulate different autophagy pathways to control autophagy events. Although the current small molecule approach is promising, it must be complemented by other approaches. 13 With the rapid development of nanotechnology, nanomaterial-based products have been widely used in various industries, medicine, and more than 1300 marketed consumer products. A thorough understanding of the mechanisms that nanoparticles use to perturb biological systems, including autophagy induction, is critical for a more comprehensive elucidation of nanotoxicity. Bioactive nanomaterials may also serve as powerful tools to solve unmet medical needs, such as the development of autophagy inducers and inhibitors. Like small molecules, nanoparticles such as carbon nanotubes (CNTs) trigger cell autophagy. 14, 15 Unpredictable autophagy induction or autophagy flux blockade by nanoparticles often induces cytotoxicity. 16 However, autophagy modulation by nanoparticles may also present a potential therapeutic opportunity. Both the dimensions and surface properties of nanoparticles affect the autophagic responses of cells. 17, 18 In addition to their wide applications in industrial and consumer products, CNTs have also been explored in applications such as drug delivery, imaging enhancement, and tissue engineering inside the human body. The feasibility of modifying the surface chemistry of CNTs permits the introduction of various biological properties. We 19, 20 and other groups 21 have shown that surface functionalization of CNTs helps optimize their bioactivities for biomedical applications 21 and toxicity remediation. 19, 20 To further our previous efforts on modulating the biological activities of CNTs through surface chemistry modifications, in this investigation, we explored how surface-modified CNTs modulate cell autophagy to various manageable levels, including a complete evasion of autophagy. In addition to modulating autophagy intensity, we also report for the first time that surface ligand modification switches mTOR-dependent autophagy induction to an mTOR-independent signaling pathway.
RESULTS AND DISCUSSION
Surface-Modified Carbon Nanotubes as Cell Autophagy Probes. Cellular perturbations by nanoparticles include the induction of autophagy. 22, 23 Some modified singlewalled CNTs prevent autophagy; 24 however, the structural basis of autophagy induction remains unclear. To gain a better understanding of the role of CNT surface chemistry in autophagy regulation, we systematically investigated autophagy induction by 81 multiwalled CNTs (MWCNTs) with surface ligands modified by combinatorial chemistry ( Figure S1 , Supporting Information). This MWCNT library was designed to have maximum surface ligand structural diversity. 25, 26 To achieve this design, we selected synthetic building blocks that produce final ligands with the most diverse physicochemical properties, such as hydrophobicity, hydrogen binding, pK a , and solubility, on the basis of computational analysis. MASÀ 1 H NMR and FT-IR analyses confirmed that the diverse molecules were successfully and quantitatively linked to the MWCNTs. 20 The loading capacity of ligands on the surface of the MWCNTs was 0.3À0.4 mmol/g, as indicated by quantitatively analyzing the nitrogen content of the products after a complete amidation reaction with the precursor MWCNT-COOH. On the basis of the functional loading (0.3À0.4 mmol/g) and surface area (500 m 2 /g) of the carbon nanotubes, we estimated that the average density of the modification was approximately 4À5 modifications per 10 nm 2 . This ligand density indicated that functional groups are mainly distributed along the sidewalls of nanotubes in addition to the tube termini. This result was not surprising because strong oxidation conditions were used in the preparation of MWCNT-COOH. Because multiple oxidation and purification steps were used, trace metal impurities were very low as quantified by ICP-MS analysis of 23 trace metals (Table  S1 , Supporting Information). MWCNTs were thoroughly characterized to understand their physicochemical properties and biological interactions. Although rigorous characterization could not be performed on every MWCNT, we carefully analyzed more than 20 randomly selected and diverse MWCNTs by transmission electron microscopy, zeta potential measurement, magic angle spinning NMR, FTIR, elemental analysis, and serum protein binding assay ( Figure S1 and Table S1 , Supporting Information). These analyses demonstrated that the MWCNTs had comparable morphologies, solution electrostatic and electrodynamic properties, and serum protein binding abilities. The cytotoxicity of all 81 MWCNTs was assessed in several cell lines. Below a concentration of 100 μg/mL, MWCNTs exhibited very low cytotoxicity. All MWCNTs were stably suspended in water at a concentration of 2 mg/mL. For cell assays, MWCNTs were suspended in cell culture medium that contained fetal bovine serum proteins, which further increased the solubility and stability of the nanotube suspension. The characterizations of these 81 MWCNTs confirmed that they were highly consistent in terms of morphology, physical properties, ligand density, and stability of their aqueous suspensions. Therefore, we expect that the interactions between these MWCNTs and cells should be the result of interactions between surface-modified nanotubes and cell surface molecules.
MWCNTs Tune Cell Autophagy to Various Levels. To assess cell autophagy quickly using a high-throughput format, we stably transfected human astrocytoma U87 cells with the LC3-GFP construct to establish an autophagy reporter cell line. U87 cells are astrocyte-like and are good models of astrocytes normally found in human brains.
27 LC3 (microtubule-associated protein 1A/1B-light chain 3) is an ubiquitin-like protein.
ARTICLE
Upon autophagic stimulation, it is conjugated to phosphatidylethanolamine to form the LC3-II isoform, a marker for autophagy, 28 on the surface of autophagosomes. Thus, the formation of autophagosomes can be directly observed as fluorescent punctuates when LC3 colocalizes with autophagosomes in LC3-GFP U87 cells. Our experiment showed that the cytotoxicity of the MWCNTs was rather low at concentration of 100 μg/mL in HEK 293 cell line ( Figure S2 , Supporting Information). However, at these concentrations, the cells were subjected to a stressful condition, which might induce autophagy. MWCNT-COOH and 80 surface-modified MWCNTs were incubated with LC3-GFP U87 cells, and autophagy induction was determined on the basis of the relative number of fluorescent autophagosomes (LC3-GFP punctuates) formed. Counting the LC3-GFP punctuates allowed us to rank the autophagy-inducing capabilities of the MWCNTs (Figure 1 , Figure 2A ). Considering that the counting of fluorescent punctuates was somewhat subjective, we also quantitatively determined LC3-II protein levels by an immunoblotting assay, as described in later sections. The cellular level of LC3-II was proportional to the level of autophagy induction as assessed by fluorescent LC3-GFP punctate. Therefore, these results demonstrate that cellular autophagy can be modulated to various levels by modifying the chemical structure of the MWCNT surface ligands. Cell autophagy is very complex. Autophagy-mediated cell death is one plausible mechanisms for nanotoxicity. 16 However, autophagy is also a common mechanism for beneficial cell survival. In cancer chemotherapy, autophagy may also mediate unwanted cancer cell survival, and thus novel therapeutic agents are critical for controlling cellular autophagy. CNTs have been explored Figure 3A ,B). The significant induction of LC3 II bands confirmed that these MWCNTs induced autophagy in both cell lines. Next, we randomly selected MWCNTs that possessed different autophagy induction capabilities and again examined their autophagy induction by assessing LC3 II formation. In both cell lines, these MWCNTs induced LC3 II formation at different levels ( Figure 3C ,D), consistent with the autophagy induction capabilities indicated in our primary screening ( Figure 1 ). These results demonstrated that surface-modified MWCNTs modulate cell autophagy to different levels and that this modulation may not be limited to one single cell line. This finding enables the development of autophagy-regulating nanotherapeutics or biocompatible nanomaterials for general use.
MWCNTs with Different Chemistries Induce Autophagy by Activating Different Signaling Pathways. Autophagy is regulated by mTOR-dependent or -independent signaling pathways. 30 Pharmacological manipulation of autophagy requires flexibility in regulating various autophagyrelated pathways. 13 We next examined whether altering the chemical structure of the surface ligand of the MWCNT would change the molecular pathways involved in autophagy activation. p70S6K and p85S6K are substrates of mTOR kinase. The phosphorylation of p70S6K and p85S6K directly reflects the activation of mTOR. 31 In mTOR-dependent autophagy induction, mTOR or the phosphorylation of p70S6K/p85S6K is suppressed. Using the anti-S6K antibody recognizing the phosphorylated (active) forms of the p70S6K and p85S6K proteins, we found that rapamycin significantly suppressed the phosphorylation of both p70S6K and p85S6K, consistent with the direct inhibition of mTOR by rapamycin ( Figure 4A ). Autophagy-inducing MWCNT-COOH generated LC3 II formation and also suppressed p70 and p85 phosphorylation ( Figure 4A ). This indicates that MWCNT-COOH induces autophagy through the mTOR-dependent pathway and its autophagy induction capability is not as strong as rapamycin. MWCNTs 13 and 33 exhibited similar inhibition of phosphorylation ( Figure 4B ). However, MWCNT 41 did not inhibit mTOR, yet it significantly induced cell autophagy as shown by LC3-II formation ( Figure 3 ). This indicates that MWCNT 41 might induce autophagy through an mTOR-independent signaling pathway. Other MWCNTs, such as 9 and 11, may induce similar effects to differing extents. These results suggest that modifying the surface chemistry of MWCNTs can enable the modulation of autophagy induction by activating different cellular signaling pathways. (Table S1 , Supporting Information). First, we confirmed that both MWCNTs induced autophagy, as indicated by the number of LC3 punctuates ( Figure 5A ). To confirm these results, autophagosomes were identified by TEM in the cytosol of HEK 293 cells after treatment with MWCNT-COOH and MWCNT 41 for 4 h ( Figure 5B ). Furthermore, both MWCNTs induced cellular LC3 II formation in a dose-dependent manner, which validated autophagy induction at the molecular level ( Figure 6A ). MWCNTs were also observed in autophagosomes, demonstrating that cells tend to clear MWCNTs through the autophagic lysosomal pathway like other infectious agents. 32 Autophagy is a dynamic process including the formation of autophagosomes and the degradation of autophagosomes by lysosomes. An increased level of LC3 II, which is a marker of autophagosome formation, could be caused by either an enhanced formation of autophagosomes at a regular rate of their degradation or a blockade of the autophagosome degradation with a basal level of autophagy. Nanomaterials have been reported to have controversial roles on the autophagy flux. Some impair lysosome function and induce an accumulation of autophagosomes even at a basal level of autophagy. 22 Others enhance autophagosome formation. 33 To elucidate whether MWCNTs induced autophagy, we used a specific vacuolar-type H þ -ATPase inhibitor bafilomycin A1 to clamp the degradation of autophagosomes by lysosomes. 28 Our data showed that MWCNT-COOH or MWCNT 41 induced a higher level of LC3 II in HEK 293 cells treated with bafilomycin A1 than cells treated with bafilomycin A1 alone ( Figure 6B ). Therefore, MWCNT-COOH and MWCNT 41 induced autophagy rather than a blockade of lysosomal degradation of autophagosomes.
34
The observed autophagy induction could be partially or entirely due to the free ligands detached from the MWCNTs. To demonstrate that the autophagy induction effect is a result of surface-modified MWCNTs rather than the sole action of the free ligands, we tested the effects of free ligand molecules on autophagy induction in HEK 293 cells. A concentration of 0.04 μM was deemed equivalent to the presumed situation that 100% of the ligands were detached from the surface of the 
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MWCNTs at the experimental concentration. We treated cells with two ligand molecules (structures in Figure 6C ) at this concentration for 24 h. Although MWCNT-COOH and MWCNT 41 led to a dose-dependent increase in LC3 II formation in HEK 293 cells ( Figure 6A ), neither free ligand molecule induced these effects ( Figure 6C ). This result confirms that the surface-modified MWCNT and not the free ligand induced cell autophagy. In addition, a basal level of autophagy was observed in both U87 and HEK 293 cells (culture medium in Figure 5A and 6A), confirming that basal autophagy was necessary to maintain normal cell physiology. 35 MWCNT-COOH and MWCNT 41 are both strong autophagy inducers, but it is not clear if they activate autophagy through the mTOR-signaling pathway. To answer this, we examined the activation of mTOR and its substrate, p70S6K. MWCNT-COOH treatment inhibited the phosphorylation of both mTOR and p70S6K in a dose-dependent manner ( Figure 7A) . In sharp contrast, MWCNT 41 treatment did not reduce the phosphorylation of either of the proteins (Figure 7B, C) .
These contrasting results demonstrate that MWCNT-COOH triggers mTOR-dependent autophagy induction, while MWCNT 41 triggers mTOR-independent autophagy induction ( Figure 7D ).
Sometimes autophagy is induced when cells were under survival pressure such as cell apoptosis. 11 To test this possibility, we examined whether the two MWCNTs induced apoptosis. Comparing with the cells treated with cell culture medium, MWCNT-treated cells showed no significant increase in early apoptosis, late apoptosis, or necrosis ( Figure 8A ). We then further investigated the activation of the apoptosis signaling at the molecular level. Apoptosis is a programmed cell death process controlled by a caspase signaling cascade. Caspase 3 is its central effector, the cleavage of which indicates the execution of apoptosis. Therefore, we analyzed the caspase 3 cleavege by Western blot. Consistent with the flow cytometry data, the cleaved caspase 3 was not detected ( Figure 8B ). Our data showed that MWCNTs did not induce apoptosis in HEK 293 cells at the conditions when autophagy was ARTICLE detected. Thus, we ruled out the possibility that the MWCNT-induced autophagy was a mere reaction to survival pressure.
The differences in autophagy induction may reflect an alternate mode of interaction between the MWCNTs and the cells. Two MWCNTs may interact differently with cells, resulting in differing levels of cell internalization. To test this, we analyzed the amount of MWCNTs taken up by cells after labeling the MWCNTs with fluorescent FITC-BSA. Both MWCNTs exhibited a similar amount of cell uptake at various time points, indicating that the rate and the amount of cell uptake were similar for these MWCNTs ( Figure S4 , Supporting Information). We next examined the cell uptake by TEM and found that both MWCNTs were localized in identical cell organelles: endosomes, cytoplasm, autophagosomes, and lysosomes in addition to those bound to cell membranes (Figures 7 and 9 ). These results indicate that there is no difference in the amount of cell uptake and intracellular distribution of MWCNTs between MWCNT-COOH and MWCNT 41. Therefore, the differences in their autophagy induction mechanisms may be the result of unique interfacial interactions due to the different surface chemistries of the MWCNTs. A more likely explanation is that the two MWCNTs bind to different cell surface receptors because they are found membrane-bound before and after endocytosis (Figure 9 A,E). 
MWCNT-COOH and MWCNT 41 May Bind to Different Cell Surface Receptors. We examined several possible explanations of the differences in autophagy induction between the two MWCNTs. Perturbation of calcium flux is an established mechanism for mTOR-independent autophagy induction. 36 We first tested whether these two MWCNTs perturbed calcium flux differently. Our experimental data revealed that neither MWCNT altered calcium channel function ( Figure S5 , Supporting Information), suggesting that calcium flux perturbation is unlikely. Next, we speculated that induction of autophagy might alter gene expression profiles, particularly for those genes related to autophagy signaling. We then analyzed whether these two MWCNTs perturb autophagy-related genes using an autophagy specific PCR array of 84 autophagic genes. The mRNA expression levels of the 84 genes in HEK 293 cells after treatment with MWCNTs were compared to those in the same cells treated with cell culture medium (Table S3 , Supporting Information). A change greater than 2-fold was considered biologically significant ( Figure 10A ,B and Table 1 ). After treatment with MWCNT-COOH, IGF1 mRNA levels were downregulated by 2.08-fold compared to treatment with culture medium. However, after MWCNT 41 treatment, the expression level of IGF1 was almost unchanged (Table 1) . Autophagy is a cellular response to environmental stress signals. Many transmembrane protein act as stress sensors at the cell membrane, such as insulin-like growth factor-1 (IGF-1) receptor. 37 Deprivation of growth factors (including insulin and IGF-1) from the extracellular milieu releases the inhibitory effects of mTOR on autophagy by a series of signaling steps. 38 MWCNT-COOH suppressed IGF-1 at both the mRNA and protein levels, while MWCNT 41 did not ( Figure 10C,D) . These findings suggest that MWCNT-COOH might block stress sensor proteins or interfere with their functions in detecting extracellular stress. Because MWCNTs tend to bind to cell membranes when they interact with cells, even after they are internalized in endosomes ( Figure 9D ), we propose that MWCNT-COOH functions by preventing signaling molecules from binding to the cell membrane receptors. 39 Surface ligand modifications of MWCNT 41 altered its interactions with the cell and eliminated such effects.
The PCR array data indicated that many antiviral genes (such as IFNG, TNF) were upregulated in MWCNT-COOH-treated cells. Endotoxin levels from 0.5 to 50 EU/mL or higher may induce perturbations to immune functions, 40 activation of related receptors, 41 and expression of related genes. 42, 43 To test the possibility of MWCNT contamination, we examined the endotoxin level in two solutions of MWCNTs using Limulus Amebocyte Lysate (LAL) method. Experiments showed that endotoxin concentration in both solutions was below 0.1 EU/mL. Ruling out the possibility of endotoxin contamination, the upregulation of these genes most likely indicated an immune perturbation by MWCNTs. Because autophagy might be induced by immune signaling molecules, 44 immune perturbation by MWCNT-COOH might induce cell autophagy. By contrast, this perturbation was neutralized when cells were treated with MWCNT 41. Both IFNG and TNF mRNA levels returned to the same levels as in the medium control after MWCNT 41 treatment. Furthermore, the PCR array data revealed that the expression of IFNA2 (interferon alpha 2) was significantly reduced in cells treated with MWCNT 41 at both the mRNA and protein levels (Table 1 and Figure 10D ) compared to the culture medium control. 
IFNA2 is an immune signaling cytokine with an antiviral function. The alteration of IFNA2 expression is often associated with certain pathogenic conditions. As a stress response machinery, autophagy plays a role in balancing immune responses. 45 An early study showed that autophagy is needed to maintain IFNA2 levels during infection. 46 We thus postulate that, after surface modification, MWCNT 41 may bind to IFNA2 receptors. Previous study showed that activation or inhibition of a specific receptor was able to up-or down-regulate the expression of the corresponding ligand. 47 Binding to IFNA2 receptors may inhibit the expression of IFNA2 to such a level that autophagy is activated to balance this potential detrimental effect. However, the detailed signaling mechanism awaits further investigation ( Figure 10E ). In brief, MWCNT-COOH decreased the expression of IGF-1 and increased immune perturbations to cells, thus leading to mTOR-dependent autophagy. However, surface-modified MWCNT 41 neutralized these effects but decreased the expression of IFNA2, leading to mTOR-independent autophagy. 

CONCLUSIONS
To develop safe nanomaterials and potential nanomedicinal agents that regulate cell autophagy, we explored the possibility of controlling autophagy induction by systematically modifying the surface chemistry of MWCNTs. By analyzing autophagosome formation and autophagy-associated biomarkers, we have identified MWCNTs that yield strong autophagy induction or no autophagy induction. These findings demonstrate that potential pharmaceutical autophagy modulators and biocompatible nanomaterials can be developed through nanoparticle surface modifications. Differences in surface chemistry allow MWCNTs to trigger autophagy through different signaling pathways, demonstrating the flexibility and specificity of autophagy modulation by nanoparticles as a result of well-defined interactions with specific molecular signaling pathways.
MATERIALS AND METHODS
MWCNT Library Characterization and Endotoxin Detection. The MWCNT library was synthesized as described in our previous article. The TEM analysis of nanotubes were performed using JEOL 1200 EX Transmission Electron Microscope at 80 kV. The images were captured using an AMT 2k CCD camera. The length of the nanotubes was measured using Image Pro Plus 6.0.
For zeta potential analysis, selected MWCNTs were first diluted either in ultrapure water (18.2 MΩ) or in DMEM medium supplemented with 10% FBS to about 25 μg/mL, and their zeta potentials were measured by a laser particle size analyzer (Malvern Nano ZS, Malvern, UK).
To measure the trace metal impurities in MWCNTs, 1 mL of nitric acid was added to about 1 mg of MWCNTs in a Teflon digestion vessels. The MWCNTs were then digested at 200°C for 45 min using a microwave by MARS (CEM Corp., Matthews, NC) microwave sample preparation system. The resulting solution was diluted to a proper concentration range and subjected to ICP-MS determination.
Each MWCNT (1.0 mg) was weighed and sterilized at 121°C for 30 min. Next, 1 mL of complete cell culture medium was added, and the suspension was sonicated for 30 min. The resulting suspension (1 mg/mL) was diluted to the desired concentrations prior to use.
To determine the endotoxin level, MWCNT-COOH and MWCNT 41 were diluted to 100 μg/mL in PBS solution and incubated at 4°C for 72 h. After being centrifuged at 16000g for 30 min, the supernatant was subjected to endotoxin test using a Limulus Amebocyte Lysate (LAL) kit from Pierce. The levels of both MWCNT variants were below 0.1 EU/mL.
Reagents and Antibodies. Rapamycin (R8781), 3-methyladenine (M9281), bafilomycin A1 (B1793), FITC-BSA (A9771) were purchased from Sigma-Aldrich (St Louis, MO, USA). Staurosporine (S1882), Fluo-3 AM (S1056) were purchased from Beyotime Institute of Biotechnology (Shanghai, China). Primary antibodies against LC3B (#2775), p-p70s6k (#9206), p70s6k (#9202), p-mTOR (#2974), mTOR (#2972) and GAPDH (#2118) were purchased from Cell Signaling (Boston, MA, USA). Primary antibodies against IGF-1 (AP14099b) and β-actin (AM1021b) were purchased from Abgent (San Diego, CA, USA). Primary antibody against procaspase 3 (sc-56046) and IFNA2 (sc-73305) was purchased from Santa Cruz (Santa Cruz, CA, USA). Primary antibody against cleaved-caspase 3 (YC0006) was purchased from Immunoway (Newark, DE, USA). Horseradish peroxidase (HRP)-conjugated secondary antibodies were purchased from Biorad (Richmond, CA, USA). PVDF membranes and the Western blot luminescence reagent and Guava Nexin Reagent were purchased from Millipore (MA, USA).
LC3-GFP U87 Cell Line. The LC3-GFP U87 cell line was constructed using the retroviral vector MSCV-IRES-LC3-GFP, which was kindly provided by Mr. Michael B. Kastan of the Molecular Oncology Department of St. Jude Children's Research Hospital. The vector contains a cDNA fragment corresponding to an autophagy-specific marker, LC3, which expresses an LC3-GFP fusion protein. The vector was transfected into the U87 cell line to produce the stable GFP-expressing LC3-reporting cell line LC3-GFP U87.
Cell Culture. The LC3-GFP U87, U87, and HEK 293 cell lines were cultured in DMEM (Gibco) culture medium supplemented with 10% fetal bovine serum (Gibco), 100 U/mL of penicillin, and 100 μg/mL of stremycin (Gibco) at 37°C with 5% CO 2 . Cells at 80% confluence were trypsinized and counted for each experiment. The HEK 293 cell lines were used between passage 5 and 10.
Quantification of Autophagosomes. The LC3-GFP U87 reporter cells were seeded in confocal dishes and fixed with 4% paraformaldehyde. Laser scanning confocal microscopy (LSM 700, Zeiss, Germany) was used to acquire fluorescent images of cells. To quantify cell autophagy induction, the number of bright punctuates (autophagosomes) was counted in at least 30 cells. Three independent experiments were carried out.
Immunoblotting. After treatment, cells were harvested and lysed in the cell extraction buffer (Invitrogen, FNN0011) supplemented with proteasome inhibitor (P2714, Sigma) and 1 mM phenylmethanesulfonyl fluoride (PMSF). Equal amounts (20 μg) of protein were loaded onto SDS-PAGE for separation and then transferred onto a PVDF membrane. The membrane was blocked with 5% w/v nonfat dry milk (in TBS with 0.05% Tween-20). After incubation with the specific primary antibody (1:1000, 5% nonfat dry milk or BSA in TBS with 0.05% Tween-20) at 4°C overnight, the membrane was washed three times with TBST (TBS with 0.05% Tween-20) solution. The membrane was then incubated with secondary antibody (1:5000, in 5% nonfat dry milk, TBS with 0.05% Tween-20) at room temperature for 1 h followed by another three washes with TBST. The protein bands were developed by incubation with a luminescent reagent. ImageJ was used to quantify the band intensity.
Phospho-p70S6k Substrate Assay. Briefly, after incubating HEK 293 cells with two MWCNT variants at the concentration of 100, 50, 25 μg/mL for 24 h, cells were harvested, and equal amounts of total proteins were subjected for Western blot analysis against phosphor-p70S6K and phosphor-mTOR antibodies. β-Actin was used as a loading control.
PCR Array Analysis. After incubation with MWCNTs for 24 h, the HEK 293 cells were lysed with Trizol (Invitrogen, CA, USA), followed by mRNA extraction. Approximately 1.5 μg of mRNA was used for cDNA synthesis by Superscript III (Invitrogen, CA, USA). The cDNA was then added to the wells of an autophagyspecific PCR array plate (PAHS-084A, Qiagen). Each well (84 in all) contained an autophagy-specific gene primer mix and another five wells of housekeeping genes as controls. The PCR plate was then subjected to a two-step RT 2 PCR program (95°C for 15 s, 60°C for 60 s). The expression of 84 autophagy-specific genes was quantified by the ΔΔCt method.
Cellular Uptake. 1.0 mg of MWCNT-COOH or MWCNT 41 was dispersed in ultrapure water under sonication. The mixture solutions were then centrifuged at 16000g for 30 min to remove large aggregates. Then equal amount of MWCNTs solution and FITC-BSA solution were mixed and incubated overnight. The resulting solutions were then centrifuged at 16000g for 30 min to remove the unbound FITC-BSA. The pellet was then washed for three times and dispersed in DPBS. The concentration of the MWCNT solution was then quantified by measuring the adsorption at 260 nm. The fluorescent intensity of FITC-BSA bind MWCNT was measured by a fluorescence spectrometer (488/535 nm). The ratio between fluorescence intensity and MWCNT concentration was defined as FITC-BSA binding ratio. MWCNTs were then dispersed in full DMEM culture medium to form a final concentration of 50 μg/mL. After being incubated with HEK 293 cells for 0.5, 2, 4, 12, ARTICLE 24 h, cells were washed and collected by trypsin. Well dispersed cell solution was subjected to flow cytometry analysis.
Calcium Flux Analysis. HEK 293 cells were treated with MWCNT-COOH or MWCNT 41 at indicated concentration for 24 h. Cells were then carefully washed with DPBS for three times and collected through trypsin digestion (free of EDTA). Next, cells were loaded with 10 μM fluorescent dye Fluo-3 AM in basic DMEM medium and kept in dark at room temperature for 1 h and then at 37°C for 30 min. Cells were then washed by centrifugation for 3 times and suspended in DPBS and subjected to flow cytometry analysis. The mean fluorescence intensity of the green fluorescence channel was collected.
Identification of MWCNT Bound Proteins by LCÀMS/MS. MWCNTs (100 μg/mL) were incubated with 10% fetal bovine serum (Hyclone) in PBS at 4 h overnight. The mixture solution was washed by centrifugation at 16000g for 30 min for 3 times. The pellet was collected and digested with trypsin enzyme for 12 h at 37°C to retrieve the MWCNT bound proteins. The resulting peptide solution was then subjected to LCÀMS/MS analysis. Product ions generated by fragmentation along the peptide backbone by collision activated dissociation (CAD) were used in an automated database search against the Swissprot database using Mascot search routine.
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